Alvotech Stock Odds of Future Stock Price Finishing Under 13.37

ALVO Stock  USD 11.99  0.45  3.62%   
Alvotech's future price is the expected price of Alvotech instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Alvotech performance during a given time horizon utilizing its historical volatility. Check out Alvotech Backtesting, Alvotech Valuation, Alvotech Correlation, Alvotech Hype Analysis, Alvotech Volatility, Alvotech History as well as Alvotech Performance.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
  
At this time, Alvotech's Price To Sales Ratio is very stable compared to the past year. As of the 22nd of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.76, while Price Earnings Ratio is likely to drop (4.97). Please specify Alvotech's target price for which you would like Alvotech odds to be computed.

Alvotech Target Price Odds to finish below 13.37

The tendency of Alvotech Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 13.37  after 90 days
 11.99 90 days 13.37 
roughly 97.0
Based on a normal probability distribution, the odds of Alvotech to stay under $ 13.37  after 90 days from now is roughly 97.0 (This Alvotech probability density function shows the probability of Alvotech Stock to fall within a particular range of prices over 90 days) . Probability of Alvotech price to stay between its current price of $ 11.99  and $ 13.37  at the end of the 90-day period is about 49.75 .
Given the investment horizon of 90 days Alvotech has a beta of -0.0833. This suggests as returns on the benchmark increase, returns on holding Alvotech are expected to decrease at a much lower rate. During a bear market, however, Alvotech is likely to outperform the market. Additionally Alvotech has an alpha of 0.0168, implying that it can generate a 0.0168 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Alvotech Price Density   
       Price  

Predictive Modules for Alvotech

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alvotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alvotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
10.8112.4414.07
Details
Intrinsic
Valuation
LowRealHigh
8.6010.2313.68
Details
Naive
Forecast
LowNextHigh
10.8412.4714.09
Details
5 Analysts
Consensus
LowTargetHigh
10.2411.2512.49
Details

Alvotech Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Alvotech is not an exception. The market had few large corrections towards the Alvotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Alvotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Alvotech within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.02
β
Beta against Dow Jones-0.08
σ
Overall volatility
0.71
Ir
Information ratio -0.05

Alvotech Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alvotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alvotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Alvotech has a very high chance of going through financial distress in the upcoming years
Alvotech currently holds 1.08 B in liabilities. Alvotech has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Alvotech's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 91.43 M. Net Loss for the year was (551.73 M) with profit before overhead, payroll, taxes, and interest of 20.92 M.
Alvotech currently holds about 128.44 M in cash with (312.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Roughly 64.0% of the company shares are held by company insiders
Latest headline from zacks.com: Are Medical Stocks Lagging CareCloud This Year

Alvotech Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alvotech Stock often depends not only on the future outlook of the current and potential Alvotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alvotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding227.3 M
Cash And Short Term Investments11.2 M

Alvotech Technical Analysis

Alvotech's future price can be derived by breaking down and analyzing its technical indicators over time. Alvotech Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alvotech. In general, you should focus on analyzing Alvotech Stock price patterns and their correlations with different microeconomic environments and drivers.

Alvotech Predictive Forecast Models

Alvotech's time-series forecasting models is one of many Alvotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Alvotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Alvotech

Checking the ongoing alerts about Alvotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Alvotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Alvotech has a very high chance of going through financial distress in the upcoming years
Alvotech currently holds 1.08 B in liabilities. Alvotech has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Alvotech's use of debt, we should always consider it together with its cash and equity.
The entity reported the previous year's revenue of 91.43 M. Net Loss for the year was (551.73 M) with profit before overhead, payroll, taxes, and interest of 20.92 M.
Alvotech currently holds about 128.44 M in cash with (312.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Roughly 64.0% of the company shares are held by company insiders
Latest headline from zacks.com: Are Medical Stocks Lagging CareCloud This Year
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:
Check out Alvotech Backtesting, Alvotech Valuation, Alvotech Correlation, Alvotech Hype Analysis, Alvotech Volatility, Alvotech History as well as Alvotech Performance.
To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.70)
Earnings Share
(1.85)
Revenue Per Share
1.283
Quarterly Revenue Growth
43.997
Return On Assets
(0.08)
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.